Efficacy and Safety of Oral Rifaximin in Patients With Active Microscopic Colitis
NCT04043897
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Microscopic Colitis
Interventions
DRUG:
Rifaximin 550mg
Sponsor
Eugene F Yen, MD